NCT02507687

Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Brief summary

This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.

Interventional

Interventional study

Status:
Completed
Enrollment:
240 patients
Phase:
  • 1
  • 2
  • 3
  • 4
Protocol ID:
192024-093
Allocation:
Randomized
Intervention model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Purpose:
Treatment

 

Eligibility criteria

Participant attributes:
Male and Female

Age:

18 Years and older.

Inclusion Criteria:

Inclusion Criteria:

- Diagnosis of either Open-Angle Glaucoma or Ocular Hypertension in each eye that
require IOP lowering treatment.

Exclusion Criteria:

Exclusion Criteria:

- Eye surgery (including cataract surgery) and or eye laser surgery within the past 6
months.

- Previous use of commercially available Bimatoprost SR; concurrent enrollment in
another Allergan Bimatoprost SR study; or previous enrollment in which an implant was
received.

All the cities where the clinical studies are located

Montreal - H1V 1G5

Quebec

Montreal

More information about this study

clinicaltrials.gov